BPI-ANCA of pediatric cystic fibrosis patients can impair BPI-mediated killing ofE. coliDH5α in vitro
- 12 January 2004
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 37 (2) , 158-164
- https://doi.org/10.1002/ppul.10416
Abstract
Gram-negative bacterial lung infections and chronic bacterial colonization are major threats for pediatric cystic fibrosis (CF) patients. Besides impeded mucociliary clearance, other mechanisms that contribute to increased susceptibility to infections are presumed. The bactericidal/permeability-increasing protein (BPI), which is delivered by neutrophil granulocytes and mucosal epithelial cells, is one of the most potent innate antibiotics against Gram-negative bacteria and endotoxin. Antineutrophil cytoplasmic autoantibodies against BPI (BPI-ANCA) have been found in up to 90% of CF patients, and titers correlated inversely with lung function parameters. As major pulmonary damage is mediated by Gram-negative bacteria and their products, the question was raised as to whether BPI-ANCA can inhibit the antibiotic function of BPI in these patients. Sera of 23 pediatric CF patients were analyzed for the presence of BPI-ANCA by indirect immunofluorescence, ELISA, epitope mapping, and Western blotting. Patients' IgG were tested in a bacterial growth inhibition assay with recombinant BPI (rBPI) and an amino-terminal fragment of BPI (rBPI21) that retains antibiotic activity for inhibition of the antibiotic function of BPI against E. coli DH5α in vitro. BPI was recognized by 21 of 23 patients' sera in our detection assays. Thirteen of 23 patients' BPI-ANCA (56%) could inhibit the antibiotic function in vitro. Moreover, epitope mapping over the whole BPI sequence revealed that more patients' BPI-ANCA recognize the amino-terminal part of BPI than can be detected by ELISA. Thus, in pediatric CF patients, BPI-ANCA may contribute to diminished bacterial clearance by inhibiting the antibiotic function of BPI. Pediatr Pulmonol. 2004; 37:158–164.Keywords
Funding Information
- DFG (Schu 1308/1-3)
- Kompetenznetzwerk Rheuma and Forschungsschwerpunkt Körpereigene Infektabwehr
- Medical University of Lübeck
This publication has 26 references indexed in Scilit:
- Cytokines in innate host defense in the lungJournal of Clinical Investigation, 2002
- The Carboxyl-terminal Domain of Closely Related Endotoxin-binding Proteins Determines the Target of Protein-Lipopolysaccharide ComplexesJournal of Biological Chemistry, 2002
- Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for the evaluation of anti-inflammatory treatment (BEAT) study groupEuropean Respiratory Journal, 2000
- Antineutrophil Cytoplasmic Autoantibodies (ANCA) in Children with Cystic FibrosisJournal of Autoimmunity, 1998
- Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitisKidney International, 1998
- Biochemical Characterization of Recombinant Fusions of Lipopolysaccharide Binding Protein and Bactericidal/Permeability-increasing ProteinJournal of Biological Chemistry, 1997
- Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosisQJM: An International Journal of Medicine, 1996
- Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosisKidney International, 1995
- Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate.Journal of Clinical Investigation, 1995
- Pathogenesis of cystic fibrosisPublished by Elsevier ,1993